Navigation Links
BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
Date:11/15/2007

BIRMINGHAM, Ala., Nov. 15 /PRNewswire/ -- BioHorizons Implant Systems, Inc. has introduced a new line of Tapered Internal Implants that feature a unique thread design and proven surface engineering technology. This product introduction is the first from BioHorizons to address the tapered market segment which account for over 50% of the U.S. dental implant market.

The Tapered Internal Implants incorporate the Laser-Lok(R) precision laser collar surface treatment, which controls cellular growth and directs hard and soft tissue attachment onto dental implants. The result of over 15 years of evidence-based research and documented clinical trials, the patented 8 and 12 micron Laser-Lok(R) channels play a vital role in inhibiting epithelial downgrowth and attaching and retaining crestal bone. The implant design and surface treatment displayed improved hard and soft tissue response leading to excellent esthetic results in animal and human clinical trials.

"These new implants will offer supreme esthetic and clinical results to our global dental implant customers," commented Steve Boggan, President and CEO of BioHorizons. "Building on BioHorizons' commitment to science, innovation and service, we are pleased to bring such a novel product to the dental implant industry."

About BioHorizons

BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. BioHorizon's flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. The Company was purchased by HealthpointCapital in 2006. BioHorizons has a strong product offering of dental implants including internal hex, external hex, overdenture and one-piece implants. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. The company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors. http://www.biohorizons.com

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the musculoskeletal sector -- specifically orthopedics and dental.

Our cumulative 85 years of experience in healthcare technology, research and private investing helps our clients capitalize on the explosive growth and unique investment opportunities in one of the fastest growing sectors of the medical device industry.

HealthpointCapital manages $650 million of institutional capital. http://www.healthpointcapital.com

Contact: Steve Boggan, President and CEO of BioHorizons, (205) 967-7880.


'/>"/>
SOURCE BioHorizons Implant Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... ... Data Management Solution Providers list for its expertise in eClinical Solutions. DDi has ... to serve the technology needs of global clients. DDi provides smarter technology for ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... hosted over 250 members of South Florida’s philanthropic community at its 10th anniversary ...
(Date:2/12/2016)... ... 12, 2016 , ... Coco Libre, the maker of coconut water beverages with ... Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic ... The invitation-only gifting suite, held this year at the W Hollywood Hotel, has become ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... Pittsburgh, PA (PRWEB) , ... February 12, 2016 ... ... serving families of the Pittsburgh metro area, celebrates the beginning of the latest ... help children develop social skills through art. Donations to this worthy cause are ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... SAN JOSE, Calif. , Feb. 12, 2016  SI-BONE, Inc., ... Implant System ® ("iFuse"), a minimally invasive surgical (MIS) device ... announced that National Government Services, Inc. (NGS), the Medicare Administrative Contractor ... Illinois , Maine , ... Hampshire , New York , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
Breaking Medicine Technology: